Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.
Róbak T, Gora-Tybor J, Krykowski E, Walewski JA, Borawska A, Pluźańska A, Potemski P, Hellmann A, Zaucha JM, Konopka L, Ceglarek B, Durźyński T, Sikorska A, Michalak K, Urasiński J, Opalińska J, Dmoszyńska A, Adamczyk-Cioch MB, Kuratowska Z, Dwilewicz-Trojaczek J, Boguradzki P, Deren M, Maj S, Grieb P. Róbak T, et al. Leuk Lymphoma. 1997 Jun;26(1-2):99-105. doi: 10.3109/10428199709109163. Leuk Lymphoma. 1997. PMID: 9250793 Clinical Trial.
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia.
Robak T, Błasińska-Morawiec M, Krykowski E, Hansz J, Komarnicki M, Kazimierczak M, Konopka L, Maj S, Hellmann A, Zaucha JM, Urasiński L, Zdziarska B, Kotlarek-Haus S, Usnarska-Zubkiewicz L, Kuratowska Z, Dwilewicz-Trojaczek J, Hołowiecki J, Krawczyk-Kulis M, Grieb P. Robak T, et al. Leuk Lymphoma. 1996 Jun;22(1-2):107-11. doi: 10.3109/10428199609051736. Leuk Lymphoma. 1996. PMID: 8724536 Clinical Trial.
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
Robak T, Błasinka-Morawiec M, Krykowski E, Kasznicki M, Płuzanska A, Potemski P, Hellmann A, Zaucha JM, Lewandowski K, Dmoszynska A, Hansz J, Komarnicki M, Konopka L, Durzynski T, Ceglarek B, Sikorska A, Kotlarek-Haus S, Mazur G, Urasinski I, Zdziarska B, Maj S, Kopec I, Skotnicki AB, Dwilewicz-Trojaczek J, Grieb P, et al. Robak T, et al. Leuk Lymphoma. 1996 Aug;22(5-6):509-14. doi: 10.3109/10428199609054790. Leuk Lymphoma. 1996. PMID: 8882965 Clinical Trial.
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T, Błasińska-Morawiec M, Błoński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszyńska A, Urasiński I, Zdziarska B, Dwilewicz-Trojaczek J, Hołowiecki J, Skotnicki AB. Robak T, et al. Eur J Haematol. 1999 Jan;62(1):49-56. doi: 10.1111/j.1600-0609.1999.tb01114.x. Eur J Haematol. 1999. PMID: 9918312
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia.
Robak T, Błoński JZ, Kasznicki M, Góra-Tybor I, Dwilewicz-Trojaczek J, Boguradzki P, Konopka L, Ceglarek B, Sułek J, Kuliczkowski K, Wołowiec D, Stella-Hołowiecka B, Skotnicki AB, Nowak W, Moskwa-Sroka B, Dmoszyńska A, Calbecka M. Robak T, et al. Leukemia. 2001 Oct;15(10):1510-6. doi: 10.1038/sj.leu.2402216. Leukemia. 2001. PMID: 11587207 Clinical Trial.
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dmoszyńska A, Wojtaszko M, Skotnicki AB, Nowak W, Hellmann A, Lewandowski K, Zdziarska B, Konopka L, Ceglarek B, Dwilewicz-Trojaczek J, Boguradzki P, Kuliczkowski K, Sułek K, Warzocha K. Robak T, et al. Med Sci Monit. 2005 Oct;11(10):PI71-9. Epub 2005 Sep 26. Med Sci Monit. 2005. PMID: 16192912 Clinical Trial.
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).
Robak T, Blonski JZ, Gora-Tybor J, Jamroziak K, Dwilewicz-Trojaczek J, Tomaszewska A, Konopka L, Ceglarek B, Dmoszynska A, Kowal M, Kloczko J, Stella-Holowiecka B, Sulek K, Calbecka M, Zawilska K, Kuliczkowski K, Skotnicki AB, Warzocha K, Kasznicki M; Polish Leukemia Group (PALG CLL2). Robak T, et al. Blood. 2006 Jul 15;108(2):473-9. doi: 10.1182/blood-2005-12-4828. Epub 2006 Mar 21. Blood. 2006. PMID: 16551966 Free article. Clinical Trial.
Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M, Dwilewicz-Trojaczek J, Wiater E, Zdunczyk A, Dybowicz J, Dmoszynska A, Wojtaszko M, Zdziarska B, Calbecka M, Kostyra A, Hellmann A, Lewandowski K, Stella-Holowiecka B, Sulek K, Gawronski K, Skotnicki AB, Nowak W, Zawilska K, Molendowicz-Portala L, Kloczko J, Sokolowski J, Warzocha K, Seferynska I, Ceglarek B, Konopka L. Robak T, et al. Blood. 2007 May 1;109(9):3672-5. doi: 10.1182/blood-2006-08-042929. Epub 2007 Jan 5. Blood. 2007. PMID: 17209059 Free article. Clinical Trial.
81 results